Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

Satoshi MinamiTakayuki HamanoHirotsugu IwataniMasayuki MizuiYoshiki KimuraYoshitaka Isaka

Published in: Clinical and experimental nephrology (2017)

TLV promotes the excretion of sodium and urea. The change in [U-Cr] is useful for early discrimination of responders. Hypotension should be carefully monitored during high-dose TLV therapy.

Keyphrases

high dose
low dose
stem cell transplantation
heart failure
mesenchymal stem cells
bone marrow
replacement therapy